Goldman Sachs analyst Robert Cox upgraded Brown & Brown to Buy from Neutral with a price target of $83, down from $84. The analyst expects Brown & Brown to see the greatest upward organic growth revisions among its coverage universe. The firm views the company as a relative winner should interest rates follow the forward curve, and sees an attractive valuation with “underappreciated consistent” free cash flow. Brown & Brown is best positioned to benefit from an accelerating hard market in employee benefits and has unique exposure to still early-stages flow of personal lines policies, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BRO:
- Brown & Brown, Inc. announces 2023 fourth-quarter earnings release and conference call dates
- Brown & Brown, Inc. enters into agreement to acquire Caton-Hosey Insurance
- Brown & Brown to acquire Caton-Hosey Insurance, terms not disclosed
- Brown & Brown just downgraded at Keefe Bruyette, here’s why
- Brown & Brown initiated with neutral view at BofA, here’s why
